ExLibris header image
SFX Logo
Title: Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study
Source:

Plos One [1932-6203] Troya, Jesús yr:2016


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO

Expand list of advanced services Advanced